Medifast, Inc. Announces Second Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Medifast (MED) Tops Q2 EPS by 3c, Revenues Beat; Raises FY19 EPS/Revenue Guidance
August 1, 2019 5:51 PM EDTMedifast (NYSE: MED) reported Q2 EPS of $1.75, $0.03 better than the analyst estimate of $1.72. Revenue for the quarter came in at $187.1 million versus the consensus estimate of $182.26 million.
Record revenue up 59.5% to $187.1 millionNet income up 51.3% to $21.4 million55.3% growth in active earning OPTAVIA Coaches to 30,600Earnings per diluted share ("EPS") of $1.75, an increase of 50.9%"These record results are another demonstration of Medifast's continued commitment to delivering sustainable growth through our mission to offer the... More
